Immuneering Cash from Financing (TTM) Trends

Immuneering Corp (IMRX)

1.49 +0.01 (+0.68%) USD | NASDAQ | Apr 30, 15:53

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	28.44M
September 30, 2023	28.25M
June 30, 2023	28.21M
March 31, 2023	0.0653M
December 31, 2022	0.019M
September 30, 2022	0.2112M
June 30, 2022	118.72M

Date	Value
March 31, 2022	144.46M
December 31, 2021	144.26M
September 30, 2021	181.24M
June 30, 2021	62.75M
March 31, 2021	36.98M
December 31, 2020	37.98M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.019M

Minimum

Dec 2022

181.24M

Maximum

Sep 2021

62.43M

Average

36.98M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks